{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T01:33:20Z","timestamp":1788140000448,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.clbc.2023.03.004","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T20:49:02Z","timestamp":1678222142000},"page":"447-453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mild Cryotherapy for Prevention of Paclitaxel-Induced Nail Toxicity in Breast Cancer Patients: A Phase II Single-Arm Clinical Trial"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1494-3312","authenticated-orcid":false,"given":"Cristina","family":"Mazzega-Fabbro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Polesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Spazzapan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta","family":"Meneghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Montagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianna","family":"Tabaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Bartoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Puglisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9 suppl 2","key":"10.1016\/j.clbc.2023.03.004_bib0001","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1634\/theoncologist.9-suppl_2-24","article-title":"Docetaxel and paclitaxel in the treatment of breast cancer: a review of clinical experience","author":"Crown","year":"2004","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.clbc.2023.03.004_bib0002","first-page":"144","article-title":"Managing taxane toxicities","volume":"11","author":"Markman","year":"2003","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.clbc.2023.03.004_bib0003","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1684\/ejd.2016.2833","article-title":"Dermatological adverse events with taxane chemotherapy","volume":"26","author":"Sibaud","year":"2016","journal-title":"Eur J Dermatol"},{"issue":"2","key":"10.1016\/j.clbc.2023.03.004_bib0004","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/annonc\/mdg050","article-title":"Taxane-induced nail changes: incidence, clinical presentation and outcome","volume":"14","author":"Minisini","year":"2003","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2023.03.004_bib0005","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/bjd.13743","article-title":"The risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta-analysis","volume":"173","author":"Capriotti","year":"2015","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.clbc.2023.03.004_bib0006","first-page":"1375","article-title":"Cryotherapy for docetaxel-induced hand and nail toxicity: randomised control trial","volume":"22","author":"McCarthy","year":"2014","journal-title":"Support Care Cancer"},{"issue":"12","key":"10.1016\/j.clbc.2023.03.004_bib0007","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jamadermatol.2018.3465","article-title":"Evaluation of prevention interventions for taxane-induced dermatologic adverse events: a systematic review","volume":"154","author":"Marks","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.clbc.2023.03.004_bib0008","first-page":"e13118","article-title":"Prophylactic management for taxane-induced nail toxicity: a systematic review and meta-analysis","volume":"28","author":"Huang","year":"2019","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.clbc.2023.03.004_bib0009","first-page":"e13118","article-title":"Preventing taxane-related peripheral neuropathy, pain and nail toxicity: a prospective self-controlled trial comparing hilotherapy with frozen gloves in early breast cancer","volume":"28","author":"Coolbrandt","year":"2022","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.clbc.2023.03.004_bib0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejon.2011.06.007","article-title":"Taxane-induced nail changes: predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity","volume":"16","author":"Can","year":"2012","journal-title":"Eur J Oncol Nurs"},{"issue":"9","key":"10.1016\/j.clbc.2023.03.004_bib0011","first-page":"2017","article-title":"Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients","volume":"20","author":"Ishiguro","year":"2012","journal-title":"Support Care Cancer"},{"issue":"19","key":"10.1016\/j.clbc.2023.03.004_bib0012","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1200\/JCO.2005.15.651","article-title":"Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand","volume":"23","author":"Scott\u00e9","year":"2005","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2023.03.004_bib0013","first-page":"5005","article-title":"Cryotherapy for the prevention of weekly paclitaxel-induced peripheral adverse events in breast cancer patients","volume":"28","author":"Shigematsu","year":"2020","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.clbc.2023.03.004_bib0014","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1684\/ejd.2011.1390","article-title":"Frostbite as a complication of frozen gloves in the prevention of docetaxel-induced onycholysis","volume":"21","author":"Begon","year":"2011","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clbc.2023.03.004_sbref0015","series-title":"Poster Session Abstracts","first-page":"1114","article-title":"Prospective study of ice gel pack as less expensive alternative for prevention of skin and nail toxicity in patients with breast cancer receiving docetaxel","author":"Matsumoto","year":"2009"},{"issue":"3","key":"10.1016\/j.clbc.2023.03.004_bib0016","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10549-017-4268-7","article-title":"A prospective randomized controlled trial of hydrating nail solution for prevention or treatment of onycholysis in breast cancer patients who received neoadjuvant\/adjuvant docetaxel chemotherapy","volume":"164","author":"Kim","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.clbc.2023.03.004_bib0017","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2702.2005.01121.x","article-title":"Pain: a review of three commonly used pain rating scales","volume":"14","author":"Williamson","year":"2005","journal-title":"J Clin Nurs"},{"issue":"6","key":"10.1016\/j.clbc.2023.03.004_bib0018","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/sim.721","article-title":"Sample size tables for exact single-stage phase II designs","volume":"20","author":"A'Hern","year":"2001","journal-title":"Stat Med"},{"issue":"7","key":"10.1016\/j.clbc.2023.03.004_bib0019","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/cncr.23333","article-title":"Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot","volume":"112","author":"Scott\u00e9","year":"2008","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.clbc.2023.03.004_bib0020","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000497824","article-title":"Management and outcome of taxane-induced nail side effects: experience of 79 patients from a single centre","volume":"5","author":"Alessandrini","year":"2019","journal-title":"Skin Appendage Disord"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923000575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923000575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:24:36Z","timestamp":1761513876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820923000575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1526820923000575"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2023.03.004","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mild Cryotherapy for Prevention of Paclitaxel-Induced Nail Toxicity in Breast Cancer Patients: A Phase II Single-Arm Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2023.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}